Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
Completed · Phase 2
Conditions studied: Lymphoma
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with allogeneic or autologous peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Phase II trial to compare the effectiveness of allogeneic stem cell transplantation with that of autologous peripheral stem cell transplantation in treating patients who have non-Hodgkin's lymphoma or Hodgkin's disease.
Key facts
- Study ID
- NCT00005613
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
- People needed
- 147
- Starts
- 1996-03-01
- Expected to finish
- 2010-06-01
- Last updated by the study team
- 2013-06-04
Who can join
Age: 15 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Florida Cancer Specialists — Fort Myers, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.